Trials / Conditions / Unresectable Synovial Sarcoma
Unresectable Synovial Sarcoma
4 registered clinical trials studyying Unresectable Synovial Sarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposert NCT05711615 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatme NCT03063632 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY NCT02650986 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Completed | Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B NCT03009201 | OHSU Knight Cancer Institute | Phase 1 |